WisdomTree Japan Hedged Health Care Fund
DXJH
DXJH was delisted on the 16th of March, 2018.
5 hedge funds and large institutions have $1.04M invested in WisdomTree Japan Hedged Health Care Fund in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
54% less capital invested
Capital invested by funds: $2.25M → $1.04M (-$1.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$114K |
| 2 |
Morgan Stanley
New York
|
+$5.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$1.47M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$15.5K |
DXJH Hedge Fund Activity: Q4 2017 in Review
5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in WisdomTree Japan Hedged Health Care Fund (DXJH) for Q4 2017, worth a combined $1.04M — down 54% from $2.25M a quarter earlier.
Fund positioning in DXJH was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $114K. The largest seller was Jane Street, cutting an estimated $1.47M.
- 5 institutional investors held WisdomTree Japan Hedged Health Care Fund (DXJH) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $1.04M of WisdomTree Japan Hedged Health Care Fund stock for Q4 2017, down 54% quarter-over-quarter.
- 0 funds opened new WisdomTree Japan Hedged Health Care Fund positions in Q4 2017 and 0 closed out.
- The largest WisdomTree Japan Hedged Health Care Fund buyer in Q4 2017 was Susquehanna International Group, an estimated $114K added.
- The largest WisdomTree Japan Hedged Health Care Fund seller in Q4 2017 was Jane Street, an estimated $1.47M sold.
Based on aggregated 13F filings for Q4 2017.